Buy Bio-Path Holdings Stock | BPTH Stock Price & Latest News | Public.com
BPTH

Bio-Path Holdings

$0.00 (0.00%)Today
    Small Market Cap
    View Bio-Path Holdings (BPTH) stock trends here

    About BPTH

    Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.27
    -0.54
    -0.8
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.45

    Actual EPS
    Q2 2021

    Stats

    Market Cap$46,27M
    Volume31,83k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$24.34
    1 Year Low$3.12
    Open$6.65
    High$6.65
    Low$6.46

    Buy any stock with any amount of money.

    Download the App
    Download the app